The Pfizer Foundation Improving Access to Cancer Care in Rwanda and Kenya
The Pfizer Foundation is supporting organizations that seek to address the increasing global burden of non-communicable diseases (NCDs) by improving access to equitable oncology care.
Estimates project that as many as 1 million people in African could die from cancer by 2030, while 70 percent of all current cancer deaths occur in low- and middle-income countries. In Africa, The Pfizer Foundation is supporting initiatives by AMPATH (Academic Model Providing Access to Healthcare) in Kenya, and Partners in Health in Rwanda to improve the treatment and prevention of breast cancer, which is among the leading cancers for women in sub-Saharan Africa. These two projects work to build capacity and strengthen infrastructure through health care worker training and technical assistance, and improve access to information, diagnostics and care through community outreach and mobilization.
The Pfizer Foundation is a charitable organization established by Pfizer Inc. It is a separate legal entity from Pfizer Inc. with distinct legal restrictions.